Graham Capital Management, L.P. Veracyte, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Veracyte, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 21,787 shares of VCYT stock, worth $853,614. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,787
Previous 17,571
23.99%
Holding current value
$853,614
Previous $597,000
44.39%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$305 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$259 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$165 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$160 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.8B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...